WASHINGTON--(BUSINESS WIRE)--New research reveals the harmful impacts of the Inflation Reduction Act’s drug pricing provisions on biopharmaceutical investment, research and development, ...

US inflation cooled broadly in March, indicating some relief for consumers prior to widespread tariffs that risk contributing ...

Inflation rose in March at a slower pace than expected but remained well above the Federal Reserve's goal as the central bank prepares to monitor the impact of tariffs on consumer prices in the ...

(It doesn't specify a timeframe.) Federal inflation data doesn't yet show much tariff impact, economists said. In fact, in a "darkly ironic" way, the specter of a global trade war may have had a ...

Potential Impact of Trump's Trade War on Jobs and Inflation Sends US Consumer Sentiment Plunging WASHINGTON (AP) — U.S. consumer sentiment plunged in April, the fourth consecutive month of ...

These numbers tell an important story: The IRA has inflicted a chilling effect on small molecule drug research and development ... We measure their impact on current clinical practices in close ...

The uncertainty is keeping Federal Reserve officials in wait-and-see mode as they look for more clarity on the impact the levies will have on inflation — and the economy more broadly.

Vital Transformation’s research found that aggregate small molecule investments by companies valued at less than $2 billion dropped by 68% since the Inflation Reduction Act was introduced.

Small-molecule drug investment has fallen 68%—and 74% for diseases mainly affecting Medicare patients—since the IRA was introduced WASHINGTON, April 14, 2025--(BUSINESS WIRE)--New research reveals the ...